http://www.newser.com/2008 - Newseren-usNewser Feed GeneratorThu, 28 Aug 2008 8:02:12 CDThttp://www.newser.com/story/30663/8-meds-docs-wont-take.html?refid=rss_all_defaultSome drugs have such serious drawbacks that even doctors won’t take them, Men’s Health reports. The big eight: Advair: Can actually increase the severity of asthma attacks Avandia: Diabetes drug carries risk of heart attackhttp://www.newser.com/story/30663/8-meds-docs-wont-take.html?refid=rss_all_defaultMon, 23 Jun 2008 10:06:39 CDThttp://www.newser.com/story/25958/serious-side-effects-linked-to-avandia-fosamax.html?refid=rss_all_defaultTwo new studies have linked the popular prescription drugs Fosamax and Avandia to serious side effects, Reuters reports. Fosamax, prescribed for osteoporosis, has been tied to a type of abnormal heartbeat that can cause dizziness and fatigue. Another study links Avandia, used to treat diabetes, to a double or even triple risk of broken limbs after long-term use.http://www.newser.com/story/25958/serious-side-effects-linked-to-avandia-fosamax.html?refid=rss_all_defaultTue, 29 Apr 2008 2:55:52 CDThttp://www.newser.com/story/4995/fda-panel-votes-to-keep-avandia-on-shelves.html?refid=rss_all_defaultAn FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs.http://www.newser.com/story/4995/fda-panel-votes-to-keep-avandia-on-shelves.html?refid=rss_all_defaultMon, 30 Jul 2007 17:31:15 CDThttp://www.newser.com/story/4888/dow-sinks-further-on-credit-jitters.html?refid=rss_all_defaultStocks tumbled more than 200 points for the second day in a row, on fears that small-cap securities might be especially hard hit by a possible collapse in certain financial services. The Dow was down 208.10 to 13265.47, despite a report that the GDP grew faster this quarter than it has in a year—but the Russell 2000, which measures small stocks, dipped 1.7% into negative territory for the year.http://www.newser.com/story/4888/dow-sinks-further-on-credit-jitters.html?refid=rss_all_defaultFri, 27 Jul 2007 16:03:26 CDThttp://www.newser.com/story/2854/controversy-rages-over-diabetes-drugs-heart-risks.html?refid=rss_all_defaultTroubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting the controversy.http://www.newser.com/story/2854/controversy-rages-over-diabetes-drugs-heart-risks.html?refid=rss_all_defaultWed, 06 Jun 2007 20:46:36 CDThttp://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.html?refid=rss_all_defaultGlaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence of heart attacks among Avandia patients—0.6%—was still very small.http://www.newser.com/story/2676/glaxo-stems-stock-slide-over-avandia.html?refid=rss_all_defaultThu, 31 May 2007 4:39:12 CDThttp://www.newser.com/story/2482/fda-warned-of-avandia-risks-years-ago.html?refid=rss_all_defaultA diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week.http://www.newser.com/story/2482/fda-warned-of-avandia-risks-years-ago.html?refid=rss_all_defaultWed, 06 Jun 2007 20:46:36 CDThttp://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html?refid=rss_all_defaultThe doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks.http://www.newser.com/story/2405/drug-company-nemesis-strikes-again.html?refid=rss_all_defaultWed, 06 Jun 2007 20:46:36 CDThttp://www.newser.com/story/2375/diabetes-drug-ups-heart-risk.html?refid=rss_all_defaultA popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found.http://www.newser.com/story/2375/diabetes-drug-ups-heart-risk.html?refid=rss_all_defaultWed, 06 Jun 2007 20:46:36 CDT